Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study
Objectives Long-term use of high-dose glucocorticoids can lead to severe immunosuppression and increased risk of treatment-resistant pneumonia and mortality. We investigated the aetiology and prognostic risk factors of mortality in hospitalised patients who developed pneumonia while receiving glucoc...
Main Authors: | Lijuan Li, Xiaoying Gu, Lianhan Shang, Guolei Sun, Lingxiao Sun, Yali Ren, Jinxiang Wang, Jianliang Pan, Jiangbo Liu, Cao Bin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-10-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/10/e037419.full |
Similar Items
-
Effects of glucocorticoid immunosuppression on serum cystatin C levels
by: Gruev Todor, et al.
Published: (2009-01-01) -
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients
by: Liwen Wang, et al.
Published: (2018-04-01) -
Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.
by: Sadat-Ali Mir, et al.
Published: (2009-01-01) -
Response of Glucocorticoid Receptor Alpha and Histone Deacetylase 2 to Glucocorticoid Treatment Predicts the Prognosis of Sudden Sensorineural Hearing Loss
by: Xiuling Zhang, et al.
Published: (2019-11-01) -
Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis
by: Lisa M. Sevilla, et al.
Published: (2019-09-01)